{"database": "lobbying", "table": "lobbying_activities", "rows": [[1915914, "12432f87-3c38-4bd8-bac4-0e97f0cbe9d1", "Q4", "PRIME THERAPEUTICS", 400339576, "PRIME THERAPEUTICS", 2016, "fourth_quarter", "PHA", "H.R.4784: Lower Drug Costs Through Competition Act, support increasing generic availability.  S.2680: A bill to amend the Public Health Service Act to provide comprehensive mental health reform, and for other purposes.  S.2615: the Increasing Competition in Pharmaceuticals Act.", "HOUSE OF REPRESENTATIVES,SENATE", null, 50000, 0, 0, "2017-01-17T16:00:42-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1915914"], "units": {}, "query_ms": 17.953784903511405, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}